Renoprotection and Renin-Angiotensin System Blockade in Diabetes Mellitus
Author:
- 1 December 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 10 (12) , 325S-331S
Abstract
Diabetic nephropathy is the most common cause of end-stage renal disease (ESRD) in the United States, and accounts for 35% of all the patients with ESRD entering a dialysis program; 63% of patients with diabetic nephropathy have type II diabetes mellitus. Hypertension is a major risk factor for renal disease and is common in people with diabetes mellitus. Strategies for preventing the progression of renal failure in patients with diabetes mellitus include glycemic control, and control of blood pressure. Blocking the renin-angiotensin system (RAS) slows the progression of established diabetic nephropathy in type I diabetes mellitus, and inhibiting angiotensin II formation retards or impedes the progression from microalbuminuria to established diabetic nephropathy (macroproteinuria) in people with type I diabetes mellitus. The situation could be the same for people with type II diabetes mellitus. The ability of RAS blockade using irbesartan, an AT1 angiotensin II receptor antagonist, to slow the progression in renal failure has been compared with that of the calcium channel blocker amlodipine and placebo in a pilot study. The results suggest that blockade of the RAS, in this case with irbesartan, is at least equivalent to calcium channel blockers with respect to antihypertensive efficacy, but provides better renoprotective benefits.Keywords
This publication has 41 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic CirrhosisThe Journal of Clinical Pharmacology, 1998
- Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular PharmacotherapyThe Journal of Clinical Pharmacology, 1993
- Effect of metabolic factors and blood pressure on kidney function in proteinuric Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1993
- The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathyDiabetologia, 1993
- Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes Care in General Practice”, DenmarkDiabetologia, 1993
- Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1993
- Proteinuria, Renal Impairment, Metabolic Control, and Blood Pressure in Type 2 Diabetes MellitusArchives of internal medicine (1960), 1992
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991
- Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1990
- Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in pima indiansDiabetologia, 1988